March 31 (Reuters) - Samsung Biologics Co Ltd 207940.KS:
SAMSUNG BIOLOGICS COMPLETES ACQUISITION OF GSK'S MANUFACTURING FACILITY IN ROCKVILLE, MARYLAND
SAMSUNG BIOLOGICS CO LTD - PLANS FURTHER INVESTMENTS TO EXPAND CAPABILITIES AT ROCKVILLE SITE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.